Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
Surjan J, Grossi JD, Del Porto JA, Delfino RS, de Oliveira Cerqueira R, Lucchese AC, Magalhães E, Del Sant LC, Tuena MA, Nakahira C, Fava VAR, Steglich MS, Abdo GL, Barbosa MG, Sarin LM, Lacerda ALT. Surjan J, et al. Among authors: del porto ja. Clin Drug Investig. 2022 Oct;42(10):865-873. doi: 10.1007/s40261-022-01193-z. Epub 2022 Aug 31. Clin Drug Investig. 2022. PMID: 36044154
Motor activity and depression severity in adolescent outpatients.
Finazzi ME, Mesquita ME, Lopes JR, Fu LI, Oliveira MG, Del Porto JA. Finazzi ME, et al. Among authors: del porto ja. Neuropsychobiology. 2010;61(1):33-40. doi: 10.1159/000262178. Epub 2009 Nov 26. Neuropsychobiology. 2010. PMID: 19940518
Activity/rest rhythm of depressed adolescents undergoing therapy: case studies.
Mesquita ME, Finazzi ME, Gonçalves B, Fu-I L, Duarte LL, Lopes JR, Del-Porto JA, Menna-Barreto L. Mesquita ME, et al. Among authors: del porto ja. Trends Psychiatry Psychother. 2016 Oct-Dec;38(4):216-220. doi: 10.1590/2237-6089-2015-0053. Trends Psychiatry Psychother. 2016. PMID: 28076642 Free article.
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity.
Lucchese AC, Sarin LM, Magalhães EJM, Del Sant LC, B Puertas C, Tuena MA, Nakahira C, Fava VA, Delfino R, Surjan J, Steiglich MS, Barbosa M, Abdo G, Cohrs FM, Liberatori A, Del Porto JA, Lacerda AL, B Andreoli S. Lucchese AC, et al. Among authors: del porto ja. J Psychopharmacol. 2021 Feb;35(2):142-149. doi: 10.1177/0269881120978398. Epub 2021 Jan 9. J Psychopharmacol. 2021. PMID: 33427015
[Depression and stress: is there an endophenotype?].
Mello AF, Juruena MF, Pariante CM, Tyrka AR, Price LH, Carpenter LL, Del Porto JA. Mello AF, et al. Among authors: del porto ja. Braz J Psychiatry. 2007 May;29 Suppl 1(0 1):S13-8. doi: 10.1590/s1516-44462007000500004. Braz J Psychiatry. 2007. PMID: 17546342 Free PMC article. Review.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
Correia-Melo FS, Leal GC, Carvalho MS, Jesus-Nunes AP, Ferreira CBN, Vieira F, Magnavita G, Vale LAS, Mello RP, Nakahira C, Argolo FC, Cardoso T, Souza CDS, Fontes ATC, Ferreira MB, Araújo-de-Freitas L, Tuena MA, Echegaray MVF, Cavalcanti DE, Lucchese AC, Bandeira ID, Telles M, Lima CS, Sampaio AS, Silva SS, Marback RF, Del-Porto JA, Abreu JN, Sarin LM, Paixão CS, Carvalho LP, Machado PRL, Turecki G, Lacerda ALT, Quarantini LC. Correia-Melo FS, et al. Among authors: del porto ja. Medicine (Baltimore). 2018 Sep;97(38):e12414. doi: 10.1097/MD.0000000000012414. Medicine (Baltimore). 2018. PMID: 30235716 Free PMC article. Clinical Trial.
33 results